Transcept Pharmaceuticals Inc 4

4 · Transcept Pharmaceuticals Inc · Filed Oct 30, 2014

Form 4

Period: 2014-10-30

Director

Transactions

Disposition to Issuer
Stock option (right to buy)
2014-10-30−416→ 0 total
Exercise: $82.56Exp: 2020-01-14→ Common stock (416 underlying)
Disposition to Issuer
Stock option (right to buy)
2014-10-30−1,458→ 0 total
Exercise: $80.88Exp: 2020-02-03→ Common stock (1,458 underlying)
Disposition to Issuer
Stock option (right to buy)
2014-10-30−3,166→ 0 total
Exercise: $82.44Exp: 2021-02-02→ Common stock (3,166 underlying)
Disposition to Issuer
Stock option (right to buy)
2014-10-30−1,666→ 0 total
Exercise: $38.04Exp: 2019-01-30→ Common stock (1,666 underlying)
Disposition to Issuer
Stock option (right to buy)
2014-10-30−3,750→ 0 total
Exercise: $81.12Exp: 2022-02-01→ Common stock (3,750 underlying)
Disposition to Issuer
Stock option (right to buy)
2014-10-30−5,208→ 0 total
Exercise: $48.84Exp: 2023-01-07→ Common stock (5,208 underlying)

Holdings

Footnotes (7)

[F1]Number of shares accounts for the effect of a reverse stock split of Issuer's common stock at a ratio of one new share for every twelve shares outstanding effective just prior to the effective time of the merger of Paratek Pharmaceuticals, Inc. into a wholly owned subsidiary of the Issuer (the "Merger") pursuant to that certain Agreement and Plan of Merger and Reorganization ("Merger Agreement") by and among Issuer, Tigris Merger Sub, Inc., Tigris Acquisition Sub, LLC, and Paratek,Pharmaceuticals, Inc. ("Paratek") dated June 30, 2014 (the "stock split").
[F2]Represents the adjusted stock option exercise price reflecting the Stock Split.
[F3]Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, certain outstanding options to purchase Issuer's common stock, whether vested or unvested, with an exercise price higher than the Issuer Closing Price (as defined therein), which is $21.588, were cancelled.
[F4]Fully exercisable.
[F5]The option vests in forty-eight equal monthly installments beginning on February 27, 2011.
[F6]The option vests in forty-eight equal monthly installments beginning on February 24, 2012.
[F7]The option vests in forty-eight equal monthly installments beginning on February 7, 2013.

Documents

1 file